ExploreWatchlistsPricing
  1. JP-listed companies
  2. DAIICHI SANKYO COMPANY, LIMITED
  3. Financials
  4. Total current assets

DAIICHI SANKYO COMPANY, LIMITED (4568)

Market cap
¥5.29T
P/E ratio
17.8x
Daiichi Sankyo is a global pharmaceutical company that researches, develops and sells prescription drugs and over-the-counter medicines worldwide.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal current assets (Million JPY)YoY (%)
Mar 31, 20251,909,433-12.17%
Mar 31, 20242,174,024+45.41%
Mar 31, 20231,495,051+11.13%
Mar 31, 20221,345,271+6.06%
Mar 31, 20211,268,420-8.36%
Mar 31, 20201,384,119-0.65%
Mar 31, 20191,393,184+69.35%
Mar 31, 2018822,673-2.88%
Mar 31, 2017847,098+14.13%
Mar 31, 2016742,205+48.38%
Mar 31, 2015500,202

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat